Internal Medicine Alert – October 15, 2004
October 15, 2004
View Issues
-
Sayonara, Sinus Headaches
Headaches commonly attributed to sinus are very likely to be migraines. -
Select the Best ACE Inhibitor for Your Patient!
Survival benefits in the first year after acute MI, in patients 65 years or older, seem to differ according to specific ACE I prescribed. -
Resolution of Hepatitis C Infection
Studies on HCV infection resolution show that PBMC HCV-RNA may remain, despite clearance of the virus from plasma. -
When to Expect a Persistent Pain in the Neck
Neck pain is common among the general population. Half of those patients who report this symptom have persistent complaints at 1 year. At particular risk for persistent neck pain are those ages 45-59 years, those with chronic low back pain, and patients who ride their bicycles regularly. -
Pharmacology Update: Acamprosate Calcium Tablets (Campral®)
The FDA has approved a new drug for the management of alcohol dependence. -
Clinical Briefs
The diagnosis of hyperhidrosis, or excessive sweating, is achieved by clinical inquiry rather than laboratory testing, though quantitative metrics are available for clinical research. -
ECG Review: Atypical Chest Pain and Early Repolarization?
The ECG in the Figure was obtained from a 23-year-old male who presented with a several day history of atypical chest pain. His ECG was interpreted as consistent with an early repolarization variant. Should anything else be considered in the differential? -
Pharmacology Watch: Linking COX-2 Inhibitors and Cardiovascular Event Risk
A new and as yet unpublished study has raised increased concern about the relationship between rofecoxib (Vioxx), Mercks blockbuster COX-2 inhibitor, and cardiovascular events.